Endocannabinoids are well established as inhibitors of chemical synaptic transmission via presynaptic activation of the cannabinoid type 1 receptor (CB 1 R). Contrasting this notion, we show that dendritic release of endocannabinoids mediates potentiation of synaptic transmission at mixed (electrical and chemical) synaptic contacts on the goldfish Mauthner cell. Remarkably, the observed enhancement was not restricted to the glutamatergic component of the synaptic response but also included a parallel increase in electrical transmission. This effect involved the activation of CB 1 receptors and was indirectly mediated via the release of dopamine from nearby varicosities, which in turn led to potentiation of the synaptic response via a cAMP-dependent protein kinase-mediated postsynaptic mechanism. Thus, endocannabinoid release can potentiate synaptic transmission, and its functional roles include the regulation of gap junction-mediated electrical synapses. Similar interactions between endocannabinoid and dopaminergic systems may be widespread and potentially relevant for the motor and rewarding effects of cannabis derivatives.
INTRODUCTION
Endocannabinoids, diffusible retrograde lipidic messengers, regulate the strength of chemical synapses (reviewed in Chevaleyre et al., 2006) . The central actions of both endogenous (typically anandamide and 2-arachidonoyl-glycerol) and exogenous (i.e., derivatives of marijuana products) cannabinoids are generally mediated by activation of the cannabinoid type 1 receptor (CB 1 R) (Freund et al., 2003) . This receptor constitutes one of the most abundant G protein-coupled receptors in the mammalian brain and, although widespread, is heavily expressed in basal ganglia and prefrontal cortices, where dopamine regulation is believed to be essential for both motor control and reward mechanisms ( Van der Stelt and Di Marzo, 2003) . Regardless of the nature of the synapse (excitatory or inhibitory), the involved brain structure, or the duration of the effect (short or long term), endocannabinoids have been mostly reported to promote depression of synaptic transmission via a presynaptic mechanism (Kreitzer and Regehr, 2001; Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001; Gerdeman et al., 2002; Robbe et al., 2002; Alger, 2002; Brown et al., 2003; Chevaleyre et al., 2006) . Thus, release of endocannabinoids and/or activation of CB 1 Rs are expected to trigger synaptic depression, suggesting a general role in downregulating chemical synaptic transmission within neural circuits across the nervous system.
In contrast, no effects of the CB 1 signaling system on gap junction-mediated electrical synapses have been reported. Because of their accessibility to in vivo experimentation, identifiable auditory afferents terminating as mixed synaptic contacts on the lateral dendrite of the goldfish Mauthner (M) cell known as Large Myelinated Club endings (''Club endings'') constitute a valuable model for the study of basic mechanisms of electrical and chemical transmission in vertebrates (reviewed in Pereda et al., 2004) . The M cells are a pair of unusually large reticulospinal neurons located in the medulla of teleosts and are essential for the organization of sensoryevoked escape responses (Korn and Faber, 2005) . While excitatory chemical transmission at Club endings is mediated by glutamate (Wolszon et al., 1997) , electrical transmission is mediated via homotypic connexin 35 (Cx35) gap junction channels , the fish ortholog of the widespread mammalian neuronal connexin 36 (Cx36) (O'Brien et al., 1998; Condorelli et al., 1998) . Remarkably, synapses at these terminals are highly modifiable and undergo activity-dependent potentiation of both the electrical and chemical components of their postsynaptic response (Yang et al., 1990; Pereda and Faber, 1996; Smith and Pereda, 2003) . This potentiation is triggered by brief bursts of afferent activity and requires the activation of NMDA receptors and Ca 2+ /calmodulin-dependent kinase II (Pereda et al., 1998) .
Because CB 1 Rs were also reported to be present in teleost fish (Yamaguchi et al., 1996; McPartland et al., 2007) , including goldfish (Yazulla et al., 2000; Cottone et al., 2005; Valenti et al., 2005) , we asked whether endocannabinoids and CB 1 Rs were involved in promoting depression at these synapses, an essential requirement for the bidirectional control of the synaptic strength at these auditory afferents. Unexpectedly, we found that dendritic endocannabinoid release leads to potentiation of both electrical and chemical transmission at Club endings. This potentiating effect requires activation of CB 1 Rs and is indirectly mediated by dopamine release from nearby varicosities, which in turn leads to potentiation of the synaptic response.
RESULTS

CB 1 Receptor Activation Enhances Mixed Synaptic Transmission
Electrical stimulation of the posterior branch of the VIIIth nerve (where auditory afferents that terminate as Club endings run) evokes a distinct excitatory synaptic potential (''mixed EPSP''; Figure 1A ) composed of an early, brief gap junction-mediated electrical component (representing the electrical coupling of the presynaptic action potentials) and a delayed, longer-lasting glutamatergic response. These two components of the synaptic potential can be unambiguously identified and reliably measured during intracellular dendritic recordings due to the brief membrane time constant of the postsynaptic M cell, estimated as $400 ms (Fukami et al., 1965) . Endocannabinoids mediate their central regulatory actions via CB 1 Rs, and their activation is expected to depress chemical synaptic transmission (Chevaleyre et al., 2006) . Thus, we hypothesized that CB 1 R activation would lead to depression of the chemical component of the mixed EPSP. Instead, we found that bath application of WIN 55,212-2, a CB 1 R agonist, led to a long-lasting enhancement of both components ( Figures 1B and 1C) , averaging 136.4% ± 9.9%, p < 0.01, and 149.8% ± 13.0%, p < 0.01, of control values for the electrical and chemical components, respectively (n = 8). The parallel changes in both modalities of transmission cannot be ascribed to increased input resistance of the M cell lateral dendrite, as the amplitude of the antidromically evoked M cell spike (a reliable estimate of this cell's resistance due to the lack of active electrogenesis in soma-dendritic membrane) remained unchanged, averaging 102.6% ± 4.0% of its control value (n = 8). In addition, the observed percent increases for each synaptic component were consistently different across experiments (ANOVA, F 54.85, F crit 3.93, p < 0.001), indicating that both forms of transmission were, although simultaneously affected, differentially modified by CB 1 R activation. The enhancements were blocked by pretreatment with a combination of the CB 1 R antagonists AM251 (AM; 4 mM) and SR141716 (SR; 4 mM), confirming that the observed effects were mediated via CB 1 R activation ( Figure 1D ; electrical:
106.2% ± 5.7%, p > 0.1; chemical: 111.7% ± 7.3%, p > 0.1; n = 8). As with previous studies in this preparation (Pereda and Faber, 1996; Wolszon et al., 1997) , we chose to use a combination of blockers to overcome possible differences in drug potency related to structural differences between the mammalian CB 1 R and its teleost orthologs, which share homology of 59% to 72% (Yamaguchi et al., 1996; McPartland et al., 2007) . Also, application of CB 1 R antagonists ( Figure 1E ) did not evoke changes in the amplitude of either component of the mixed EPSP (electrical: 98.4% ± 7.5%, p > 0.5; chemical: 110.0% ± 13.2%, p > 0.1; n = 8), indicating that endocannabinoids are not tonically released in this system.
The effects of bath application of WIN could result from activation of CB 1 Rs expressed on remotely located neurons, so we asked whether local extracellular application to the surrounding area of the M cell dendrite could evoke similar enhancements of the synaptic response. For this purpose, a second recording pipette with a solution containing WIN was positioned in the vicinity of these terminals in the distal portion of the lateral dendrite ( Figure 2A ). Brief local application of WIN was sufficient to trigger a long-lasting enhancement of the mixed EPSP ( Figure 2A ; electrical: 146.5% ± 10.5%, p < 0.01; chemical: 148.0% ± 13.0%, p < 0.05; n = 6). These increases did not result from continued activation of CB 1 Rs, a possibility raised by the lipophilic nature of WIN, because they were not modified by subsequent bath application of the CB 1 R antagonists AM and SR (n = 3; data not shown).
Local WIN application suggested that endocannabinoids could mediate their actions via activation of CB 1 Rs located in the proximity of these terminals. Immunohistochemical studies with polyclonal antibodies raised against either the first 14 (anti-CB 1 1-14), the first 77 amino acids (anti-CB 1 1-77), or the carboxy terminus (anti-CB 1 -CT) of the rat CB 1 R showed distinct punctate labeling near the distal portion of the lateral dendrite (Figures 2 and 7A ) in the immediate vicinity of Club endings. This relationship is illustrated in Figure 2B , where the position of Club endings along the membrane of the M cell lateral dendrite is revealed by an antibody against Cx35 (anti-Cx35/36). Interestingly, CB 1 -labeled puncta (anti-CB 1 1-77), although very close, do not appear to be on either the Club ending or the M cell membranes ( Figure 2C ), a distribution more clearly observed in side views of these terminals ( Figure 2D ).
Dopamine Mediates WIN-Evoked Potentiation
The distribution of CB 1 -labeled puncta resembles the dopaminergic varicosities that surround Club endings at the distal portion of the M cell lateral dendrite ( Figure 3A) . Previous studies revealed that dopaminergic varicosities lie in close proximity (within a few microns) to the M cell and Club ending membranes and that brief local dopamine application evokes long-lasting enhancements of both components of the synaptic response (Pereda et al., 1992) . These enhancements require activation of dopamine D 1/5 receptors (D 1/5 Rs) that act via a postsynaptic PKA phosphorylation pathway (Pereda et al., 1994) . Thus, we hypothesized that the synaptic enhancements evoked by WIN application are mediated via dopamine release from nearby varicosities. Pretreatment with the D 1/5 R antagonist SCH-23390 (50 mM) prevented WIN-evoked enhancements of the mixed EPSP ( Figure 3B ; electrical: 94.4% ± 7.4%, p > 0.1; chemical: 98.2% ± 10.4%, p > 0.5; n = 8). Consistent with this hypothesis, WIN-evoked enhancements of the mixed EPSP were also blocked by intracellular application of PKI 5-24 (PKI), a specific PKA inhibitory peptide ( Figure 3C ; electrical: 89.4%, ± 6.6%, p > 0.1; chemical: 88.4% ± 6.0%, p > 0.1; n = 5). Furthermore, the synaptic enhancement evoked by bath application of WIN occluded the effects of locally applied dopamine ( Figure 3D ; n = 3), suggesting that both forms of potentiation share common mechanisms. In contrast, WINevoked enhancements did not occlude the long-term potentiation triggered by stimulating the posterior VIIIth nerve with brief (10 ms) high-frequency (500 Hz) trains ( Figure 3D ), which is known to follow a different, Ca 2+ -dependent intracellular signaling pathway (Pereda et al., 1998) . at 20 C-22 C (Wilson and Nicoll, 2001; Chevaleyre and Castillo, 2003) , we hypothesized that the source of their production must lie in the vicinity of dopaminergic varicosities. Furthermore, because the synthesis and release of endocannabinoids usually takes place at postsynaptic cells, often following activation of group I metabotropic glutamate receptors Varma et al., 2001; Ohno-Shosaku et al., 2001; Galante and Diana, 2004) , we hypothesized that endocannabinoids are released from the M cell dendrite. Accordingly, immunochemical analysis with confocal microscopy and an mGluR1a antibody (anti-mGluR1) revealed strong labeling at Club ending synapses ( Figure 4A ). Interestingly, labeling was not restricted to the periphery of these mixed contacts, where chemical synapses are located , suggesting the existence of an extrasynaptic distribution of mGluR1 receptors (i.e., beyond the limits of chemical synaptic domains but within the boundaries of the contact; Figures 4B and 4C ). Despite the presence of mGluR1 receptors, local application of (RS)-3,5-dihydroxyphenylglycine (DHPG; 1 mM), a group I mGluR receptor agonist, did not result in an enhancement of the mixed EPSP ( Figure 4D ; electrical: 90.8% ± 10.4%, p > 0.1; chemical: 87.8% ± 11.1%, p > 0.1; n = 6). Endocannabinoids are also known to be released following postsynaptic depolarizations (Ohno-Shosaku et al., 2001; Wilson and Nicoll, 2001; Kreitzer and Regehr, 2001) . However, as with DHPG applications, strong dendritic depolarizations (five pulses of 5 s duration and 90 nA of intensity) expected to bring the membrane potential to about 0 mV (Experimental Procedures) did not elicit changes in the amplitude of either component ( Figure 4E ; electrical: 108.0% ± 8.9%, p > 0.1; chemical: 92.9% ± 6.3%, p > 0.1; n = 6).
However, recent evidence shows that these manipulations can cooperate for the release of endocannabinoids (Ohno-Shosaku et al., 2002) . We found that when local application of DHPG was followed by dendritic depolarization, it successfully triggered lasting potentiations of the mixed EPSP ( Figure 4F ; electrical: 151.1% ± 11.5%, p < 0.01; chemical: 148.1% ± 15.0%, p < 0.05; n = 6). This protocol was more efficient (occurring in 100% of the trials) when dendritic depolarizations were applied 10 min after local application of DHPG ( Figure 4F ). This is likely due to the diffusion time required for this agonist to reach a significant number of the synaptic contacts, which are distributed along an $250 mm length of the M cell lateral dendrite. Consistent with this potentiation being mediated by endocannabinoid release, the observed effects were blocked by pretreatment with the CB 1 R antagonists AM and SR ( Figure 4G ; electrical: 108.7% ± 4.6%, p > 0.1; chemical: 105.6% ± 6.1%, p > 0.1; n = 6).
Given the properties of the mixed synaptic responses, the combined requirement of mGluR activation and dendritic depolarization suggested that patterns of activity of Club endings could be responsible for endocannabinoid release under natural conditions. Club endings represent the overwhelming majority of the excitatory inputs in this portion of the M cell lateral dendrite, and the electrical component of their mixed EPSP evokes a large dendritic depolarization that is immediately followed by a glutamatergic response (the depolarization produced by the electrical component is generally four to five times bigger than that of the glutamatergic response; Figure 5A ). Therefore, we asked whether patterns of stimulation of the posterior VIIIth nerve could trigger long-term enhancement of the synaptic response. We found that repetitive activity at 100 Hz, a frequency known to promote endocannabinoid release in other systems Chevaleyre and Castillo, 2003; Galante and Diana, 2004; Brenowitz and Regehr, 2005) , evoked long-term potentiation of the mixed EPSP ( Figure 5B ; electrical: 161.1% ± 14.0%, p < 0.05; chemical: 178.6% ± 18.2%, p < 0.05; n = 5; antidromic spike was unchanged: 97.7% ± 8.0%). This prolonged pattern of activity resembled the conditions found for endocannabinoid release ( Figure 4F ) and was radically different from that used for the induction of a distinct ''long-term potentiation,'' which required brief bursts of 10 ms duration at 500 Hz over several minutes (Yang et al., 1990) . Furthermore, the potentiation triggered by this stimulating paradigm involved endocannabinoid release, as the observed effects were blocked by pretreatment with AM and SR ( Figure 5C ; electrical: 112.2% ± 17.7%, p > 0.5; chemical: 114.0% ± 16.3%, p > 0.1; n = 5). Thus, our results indicate that endocannabinoids are produced and released on demand from the M cell lateral dendrite as a result of the activity of Club endings, leading to long-term potentiation of both components of the synaptic response via CB 1 R activation.
The endocannabinoid 2-arachidonoyl-glycerol (2-AG) has been implicated in several forms of synaptic plasticity in the mammalian nervous system (Chevaleyre et al., 2006) . Therefore, we asked whether this endocannabinoid was also responsible for the observed potentiations at goldfish mixed synapses. To explore this possibility we tested the effects of tetrahydrolipstatin (THL; 100 mM), an inhibitor of diacylglycerol lipase (DGL), which converts diacylglycerol into 2-AG, on the ability of the 100 Hz pattern of stimulation to evoke long-term changes in the synaptic strength. Intradendritic injections of THL prevented potentiation of the mixed EPSP ( Figure 5D ; electrical: 107.3% ± 6.6%, p > 0.1; chemical: 102.9% ± 7.0%, p > 0.5; n = 5).
Our data suggest that the CB 1 R mediates its effects via dopamine release from nearby varicosities. To confirm this, we tested the effects of pretreatment with the D 1/5 R antagonist SCH-23390 (50 mM) on the ability of the 100 Hz stimulation protocol to evoke long-term changes in the synaptic strength at these terminals. As illustrated in Figure 5E , SCH-23390 prevented the potentiation of the mixed EPSP (electrical: 92.3% ± 3.7%, p > 0.1; chemical: 92.3% ± 4.3%, p > 0.1; n = 5). Thus, activity-dependent production of the endocannabinoid 2-AG at the M cell lateral dendrite is sufficient to trigger local dopamine release, which in turn evokes a long-term potentiation of the mixed synaptic response.
CB 1 Receptors Are Closely Associated With Dopaminergic Varicosities
Endocannabinoids are expected to suppress transmitter release by acting on presynaptic CB 1 Rs. In contrast, our data strongly suggest that activation of these receptors leads to increased dopamine release. A mechanism compatible with the well-established conventional presynaptic effects of endocannabinoids would be that dopamine release is enhanced as a result of suppression of GABA release from nearby inhibitory terminals. This phenomenon, known as ''disinhibition,'' is proposed to occur at soma of dopaminergic neurons in the ventral tegmental area of the rat and substantia nigra of the mouse . Supporting this possibility, Club endings and dopaminergic varicosities are closely surrounded in the long and smooth (spineless) lateral dendrite of the M cell by a large number of inhibitory terminals (''small vesicle boutons'') (Tuttle et al., 1987) , which are predominantly GABAergic (Triller et al., 1993) . As in other systems, CB 1 Rs could act presynaptically on these terminals to inhibit release (Freund et al., 2003) . Given the presence of numerous inhibitory terminals in the lateral dendrite, spillover of GABA could act to influence transmitter release from nearby dopaminergic varicosities. Indeed, spillover of transmitter has been shown to occur between inhibitory synapses on the M cell (Faber and Korn, 1988) . Experimentally, these terminals can be activated by antidromically stimulating the M cell axon, as they participate in a feedback inhibitory circuit (Figure 6A) . Since the equilibrium potential of chloride (Cl À ) in the M cell lies close to its resting potential, visualization of the feedback inhibitory synaptic potential requires intracellular Cl À loading ( Figure 6B ), often difficult to maintain at constant levels. A more accurate assay for the strength of these inhibitory connections is to measure the change in membrane conductance (''shunt'') produced by the opening of ligand-gated Cl À channels. The conductance change (''fractional conductance'') is proportional to the ratio between the amplitude of the M cell antidromic spike in the absence and presence of the inhibitory synaptic potential (Oda et al., 1995) . For this purpose, a second antidromic stimulating pulse was applied 6 ms after the first, conditioning pulse ( Figure 6C ). We asked whether this ratio could be affected by local application of WIN or dendritic release of endocannabinoids (DHPG + depolarization) and found that neither manipulation led to changes in fractional conductance, averaging 105.8% ± 9.3%, p > 0.5, and 100.5% ± 7.6%, p > 0.9, respectively (n = 6). The absence of effect on dendritic inhibition did not result from the inability to detect changes in synaptic inhibition, as this ratio was increased after bath application of WIN (199.4% ± 34.7%, p < 0.05), indicating an unexpected enhancement of feedback inhibitory transmission. Because dendritic applications did not induce changes in the inhibitory synaptic response, we concluded that the observed enhancement must result from changes in feedback inhibitory neurons innervating the M cell soma (located $500 mm from the dendritic injection site), which are predominantly glycinergic ( Figure 6A ) (Triller et al., 1993) . Remarkably, this effect was not observed in the presence of CB 1 R antagonists (AM-SR), the D 1/5 R antagonist SCH-23390, or following intracellular injections of PKI; fractional conductance averaged 99.2% ± 6.4% (p > 0.5), n = 8; 100.2% ± 6.2% (p > 0.5), n = 8, and 80.0% ± 7.9% (p > 0.05), n = 5, respectively ( Figure 6D ), suggesting that the observed enhancement of synaptic inhibition was also mediated by dopamine release via a postsynaptic mechanism. In agreement, immunochemical analysis showed that both dopaminergic fibers and CB 1 Rs were distributed in the vicinity of the M cell soma (data not shown).
The lack of effect of cannabinoids on dendritic inhibition, largely GABAergic (Triller et al., 1993) , suggests that disinhibition mechanisms are unlikely to underlie dopamine release from nearby varicosities. To directly determine whether disinhibition is involved in promoting the dopamine release, we studied the effect of the GABA A antagonist bicuculline on both the amplitude of the mixed EPSP and the ability of repetitive stimulation of the VIIIth nerve at 100 Hz to trigger potentiation. If dopamine release results from a reduction of GABA inhibitory influences, the addition of bicuculline is expected to induce an enhancement of the mixed EPSP. In contrast, we found that bath application of bicuculline did not lead to changes in the baseline amplitude of either component of the mixed EPSP ( Figure 6E, bottom left) . Furthermore, pretreatment with bicuculline did not prevent activity-dependent potentiation of the electrical and chemical components of the synaptic response evoked by repetitive stimulation of the VIIIth nerve at 100 Hz (148.9% ± 16.6%, p < 0.5, and 156.4% ± 19.4%, p < 0.5, respectively; n = 5; Figure 6E , bottom right). In contrast, bicuculline abolished recurrent inhibition ( Figure 6E, top) .
Thus, our results indicate that disinhibition of dopaminergic varicosities near the lateral dendrite does not constitute the mechanism underlying dopamine release. However, recent evidence demonstrates that CB 1 Rs are presynaptically distributed in the axons and varicosities of other aminergic neurons (Oropeza et al., 2006) , suggesting that their activation could be responsible for the release of noradrenaline (Oropeza et al., 2005) . Therefore, we investigated the colocalization of CB 1 Rs and dopaminergic varicosities in the M cell lateral dendrite via double immunolabeling with anti-CB 1 -CT and anti-tyrosine hydroxylase (anti-TH) antibodies ( Figure 7A ). We found close association and overlap of CB 1 -labeled puncta and THlabeled dopaminergic fibers and varicosities in a pattern consistent with localization of these receptors on dopaminergic varicosities or processes immediately adjacent to them ( Figure 7B ). The observed distribution suggests that activation of CB 1 Rs could directly promote the dopamine release via unconventional presynaptic mechanisms. As illustrated in Figure 7A , most of the CB 1 -labeled puncta were not associated with TH-labeled fibers, indicating a wide distribution of this ubiquitous receptor in other cell types of the goldfish hindbrain. Nevertheless, the incidence of the association between CB 1 and dopaminergic varicosities was certainly underestimated, as anti-TH immunofluorescence proved to have a lower efficiency ($20%) in detecting these fibers when compared with that of anti-dopamine antibodies combined with peroxidase methods ( Figure 3A ; also Pereda et al., 1992) .
Cx35 Is a Direct Target of PKA Phosphorylation at Club Endings Cx35 contains several PKA phosphorylation sites, and PKA can directly phosphorylate Cx35 to modify its function (Mitropoulou and Bruzzone, 2003; Ouyang et al., 2005; Urschel et al., 2006) . We asked whether Cx35 could be similarly phosphorylated at Club endings. For this purpose, western blots were obtained from small areas of the goldfish hindbrain containing the M cells with a polyclonal antibody raised against a PKA phosphorylation site at serine 110 of Cx35 (anti-Cx35/P110). This antibody labeled Cx35 (two closely spaced bands at 32-33 kDa), and labeling was lost upon alkaline phosphatase digestion, suggesting that this connexin is also the target of PKA phosphorylation in neurons of this region that includes the M cells ( Figure 8A ). Accordingly, immunohistochemical studies using the anti-Cx35/P110 antibody revealed abundant punctate labeling at Club endings, which were unambiguously identified by the presence of labeling with the monoclonal anti-Cx35/36 antibody ( Figures 8B and 8C ).
DISCUSSION
Contrasting with their well-defined role in promoting depression of synaptic transmission, our results show that endocannabinoids evoked long-term enhancement of synaptic transmission at mixed contacts between Club endings and the M cell lateral dendrite. As previously demonstrated in other cell types, endocannabinoids are released from the postsynaptic dendrite (Freund et al., 2003) ; in this case, release requires simultaneous mGluR1 activation and postsynaptic depolarization. Such requirements are ideally suited to the characteristics of the synaptic potential evoked by Club endings, where glutamate release is always accompanied by the large dendritic depolarization produced by the spread of the presynaptic action potentials via the numerous gap junctions present at these terminals. Accordingly, we show that activity of these afferents leads to endocannabinoid release and subsequent potentiation of synaptic transmission, suggesting that this signaling system is likely to participate in the regulation of the synaptic strength of these afferents under natural conditions. Club endings provide the M cell with essential auditory information for the initiation of an escape response (Korn and Faber, 2005) . Activitydependent release of endocannabinoids may have an important functional role, as the increased synaptic gain of these VIIIth nerve synapses will sensitize this vital behavior, lowering its threshold to auditory stimuli.
The enhancements in transmission observed following endocannabinoid release and CB 1 R activation cannot be ascribed to possible interactions with other well-known potentiating mechanisms present at Club endings (Yang et al., 1990) , as those do not require PKA activation (Kumar and Faber, 1999; Pereda et al., 1998) . Furthermore, the stimulation pattern used to trigger the observed endocannabinoid-mediated potentiation was radically different from that used for the induction of the previously described ''long-term potentiation'' of both components of the mixed synaptic response (Yang et al., 1990 ). In contrast to that used to trigger endocannabinoid release, this protocol consists of brief (10 ms) high-frequency (500 Hz) trains of stimuli applied every 2 s during 4 min, a pattern known to optimize activation of NMDA receptors that are required for the induction of these synaptic changes (Yang et al., 1990; Pereda and Faber, 1996) . This potentiation requires an intracellular increase in Ca 2+ that in turn leads to the activation of Ca 2+ /calmodulin-dependent kinase II (Pereda et al., 1998) and was not prevented by intracellular injection of PKA inhibitors or bath application of dopamine D 1/5 R antagonists (Kumar and Faber, 1999) . Thus, our results suggest that several activity-dependent mechanisms might converge for the regulation of the synaptic strength at these auditory afferents.
Endocannabinoids Regulate the Strength of Electrical Synapses
Our data demonstrate that electrical synapses, whose functional roles in the mammalian CNS have been increasingly recognized (Connors and Long, 2004) , are the target of endocannabinoid control. Most of the known effects of cannabinoids on gap junctional communication are so far restricted to nonneural tissue (Brandes et al., 2002; Upham et al., 2002) . In the nervous system, the endogenous cannabinoid anandamide was reported to decrease junctional conductance between cultured astrocytes, although this effect was not mediated via activation of CB 1 Rs (Venance et al., 1995) . Given that electrical transmission at these terminals is mediated by Cx35 , the fish ortholog of the widespread neuronspecific Cx36 (O'Brien et al., 1998; Condorelli et al., 1998) , our results suggest that mammalian electrical synapses could be similarly regulated. Endocannabinoids, in particular 2-AG, have a well-established role in modulating chemical synaptic transmission (Alger, 2002; Freund et al., 2003; Chevaleyre et al., 2006) . The present results show that their modulatory role is not restricted to a specific modality of synaptic transmission, and they suggest a general role for the endocannabinoid system in shaping interneuronal communication in general. CB 1 R-evoked dopamine release potentiated both forms of transmission via postsynaptic activation of PKA. Ionotropic glutamate receptors are known to be targets of PKA modulatory action in a variety of experimental preparations where PKA phosphorylation mediates changes of synaptic transmission (Swope et al., 1999) . Both Cx35 and its mammalian ortholog Cx36 have also been shown to be targets of PKA phosphorylation (Mitropoulou and Bruzzone, 2003; Ouyang et al., 2005; Urschel et al., 2006) . We show here that Cx35 is phosphorylated at regulatory PKA phosphorylation sites in Club endings. Thus, endocannabinoid release is likely to potentiate electrical transmission via a direct action on this connexin.
Synaptic Potentiation Is Mediated via the Release of Dopamine
The effects of cannabinoids required both CB 1 and D 1/5 receptor activation, indicating that potentiation is mediated indirectly via dopamine release. We previously showed the presence of a rich dopaminergic innervation in the vicinity of the M cell lateral dendrite and demonstrated that local dopamine application is sufficient to trigger a lasting potentiation of both components of the synaptic response (Pereda et al., 1992) . We show now that dopamine release is under the regulatory control of local factors such as dendritic endocannabinoid production. Thus, by the action of neurotransmitter modulators, endocannabinoids can amplify and promote regulatory actions that go beyond their conventional effects on synaptic transmission. Furthermore, because endocannabinoids are thought to travel no more than 10-20 mm, dopamine release could also act to spatially amplify their regulatory effects, as this less lipophilic neurotransmitter would diffuse a greater distance along the dendritic tree.
We found a close association of CB 1 Rs with dopaminergic varicosities, suggesting their localization on these terminals. While this possibility is consistent with the classical distribution of these receptors on presynaptic terminals, it is in contradiction with the conventional suppressive effects of CB 1 Rs on synaptic transmission (Freund et al., 2003) , as activation of these receptors would lead instead to increased dopamine release. Recently, similar presynaptic distribution of CB 1 Rs was reported in the axons and varicosities of other monoaminergic neurons (Oropeza et al., 2006) , where they have been proposed to promote release of noradrenaline (Oropeza et al., 2005) . Taken together, these findings raise the possibility that CB 1 Rs located on monoaminergic varicosities could be coupled to alternative signaling pathways, making them capable of enhancing transmitter release. Consistent with this possibility, recent evidence shows that CB 1 Rs are not exclusively coupled to Gi/o (which is in turn negatively coupled to adenylate cyclase) but also to Gq/11 (Lauckner et al., 2005) and Gs (Glass and Felder, 1997) , suggesting that intracellular signaling triggered by activation of these receptors could be more diverse than originally anticipated. Supporting these observations, studies in slices of globus pallidus (Maneuf and Brotchie, 1997) , cultured striatal neurons (Glass and Felder, 1997; Jarrahian et al., 2004) , and chinese hamster ovary cells (Bonhaus et al., 1998) reported that CB 1 R activation can lead to increases in the intracellular concentration of cAMP. Furthermore, activation of CB 1 Rs in neuroblastoma cells was shown to promote an increase in cytoplasmic Ca 2+ levels through a pathway involving both Gs and PKA (Rubovitch et al., 2002; Bash et al., 2003) . Thus, the ability of these receptors to promote increases in cAMP and intracellular Ca 2+ opens the possibility that similar mechanisms could underlie enhanced transmitter release from dopaminergic varicosities. Finally, CB 1 Rs could enhance dopamine release by modifying presynaptic excitability and/or the properties of presynaptic action potentials, as these receptors have been shown to target K + currents in goldfish retinal bipolar cells (Fan and Yazulla, 2005 ). An alternative possibility that we considered was that CB 1 Rs located on nearby inhibitory terminals or processes that are presynaptic to dopaminergic varicosities act to regulate GABA release. This mechanism seems highly unlikely given the lack of effect on dendritic inhibition and the absence of direct contacts with either the M cell or presynaptic terminals in serial EM reconstructions of dopaminergic varicosities (Pereda et al., 1992) . This possibility was directly ruled out in experiments where activity-dependent potentiation was observed in the presence of blockers of GABAergic transmission, indicating that inhibition is not required for the induction or expression of this potentiation. Thus, our results indicate that dopamine release is not mediated by ''disinhibition'' of dopaminergic varicosities, and therefore, activation of the CB 1 R must necessarily increase dopamine release directly.
Enhancement of Inhibitory Synaptic Transmission
Interestingly, our results show that while inhibitory synapses on the M cell lateral dendrite are insensitive to CB 1 R activation, those targeting the soma were enhanced by CB 1 R activation. This finding represents a novel endocannabinoid regulatory action, as inhibitory transmission in hippocampus and neocortex is consistently reported to be depressed by CB 1 R activation (Freund et al., 2003; Chevaleyre et al., 2006) . Because inhibitory synapses on the soma are predominantly glycinergic (Triller et al., 1993) , the results suggest the existence of a differential sensitivity of the predominantly GABAergic dendritic inhibitory synapses to endocannabinoid modulation. Our results show that this enhancement of somatic inhibition is also mediated by dopamine and a PKA-dependent postsynaptic mechanism. Consistent with these findings, intracellular injections of cAMP or aminophylline (that inhibits phosphodiesterase and therefore cAMP degradation) in the M cell soma have been shown to enhance feedback inhibition (Wolszon and Faber, 1989) . Because dendritic release of endocannabinoids did not affect feedback inhibition (consistent with limited diffusion of these lipidic messengers), a second source of endocannabinoid release seems to be required to modify inhibitory synaptic transmission at the soma. Thus, our findings suggest that neurons could be endowed with multiple sites of endocannabinoid production to modulate the strength of synaptic inputs at specific cellular compartments.
Endocannabinoids and Dopamine Function
Behavioral, biochemical, and electrophysiological data have increasingly implicated the involvement of dopamine in the central actions of cannabinoid compounds (Van der Stelt and Di Marzo, 2003) . However, the sites and cellular mechanisms by which cannabinoids and dopamine systems interact remain to be determined. We describe here a novel form of interaction between these two systems in which dendritic endocannabinoid production is capable of inducing local release of dopamine from nearby varicosities. Localized interactions between cannabinoid and dopaminergic systems could constitute a more general property relevant to structures where dopamine and endocannabinoid signaling coexist, such as basal ganglia (Marsicano and Lutz, 1999; Hohmann and Herkenham, 2000) and prefrontal cortex (Herkenham et al., 1990) , and contribute to the motor and addictive effects of the marijuana products. These interactions might also be relevant to the retina, which contains dopamine receptors, abundant gap junctions, and CB 1 Rs (Fan and Yazulla, 2005) .
EXPERIMENTAL PROCEDURES Electrophysiology
Intracellular in vivo recordings from adult goldfish (Carassius auratus) were performed as previously described (Pereda et al., 1994) . Briefly, responses to VIIIth nerve or spinal cord stimulation were recorded from the lateral dendrite of the M cell (300-400 mm from the axon hillock) with glass microelectrodes (4-7 MU) containing 5 M K-Acetate, pH 7.2. Due to the brief membrane time constant of the M cell ($400 ms), both components of the synaptic potential can be unambiguously identified and reliably measured, as the brief duration of the electrical component does not significantly influence the peak of the subsequent chemical response (peak amplitudes were detected within a range of points using Igor software). Synaptic potentials were monitored every 4 s, and traces were averaged in sets of ten or more. Amplitude changes were estimated by comparing averages obtained at baseline and 30 min after each experimental manipulation. Results are expressed as mean ± SEM. Student's t test was used to assess statistical significance of the data, unless otherwise stated (level of significance: 5%). The amplitude of the M cell antidromic action potential was routinely monitored and taken as an indicator of the cells' input resistance. The strength of the feedback inhibition was quantified by measuring amplitude changes in a second antidromic action potential (6 ms interval) superimposed on the inhibitory response (the reduction in amplitude of the second action potential is proportional to the membrane shunting produced by the opening of ligand-gated Cl À channels) and expressed as the ratio between the amplitudes of the first, conditioning, action potential (V) and the second, or ''test,'' action potential. This ratio, ''fractional conductance,'' was defined as (V/V 0 ) À 1 (Oda et al., 1995) . In order to activate the auditory afferents, a bipolar stimulating electrode (FHC, Brunswick, ME) was placed on the posterior VIIIth nerve. To obtain ''long-term potentiation'' of the mixed EPSP, high-frequency stimulation of the posterior VIIIth nerve, consisting of six pulses at 500 Hz applied every 2 s, was applied over 4 min (''TET'' in Figure 3D ). In the case of dendritic depolarizations, the protocol consisted of a total of five pulses of 90 nA, 5 s duration each, applied every 4 s through the recording electrode; this amount of current is expected to bring the membrane potential to approximately 0 mV (estimated input resistance $1 MU) (Pereda et al., 1992; Wolszon et al., 1997) .
Drug Application WIN 55,212-2 (500 nM; Tocris), SR141716 (4 mM; NIMH Drug Supply program), AM251 (4 mM; Tocris), SCH-23390 (50 mM; Biomol), and bicuculline methiodide (75 mM; Sigma) were bath-applied by superfusion of the brain after dilution in artificial CSF. WIN 55,212-2, SR141716, AM251, and tetrahydrolipstatin (THL) were prepared from 5 mM stocks in DMSO. For extracellular local application, a second microelectrode (12-16 MU) was positioned 300-400 mm from the axon hillock and 20-30 mm above the M cell lateral dendrite. WIN (5 mM), (RS)-3,5-dihydroxyphenylglycine (DHPG; 1 mM; Tocris) or dopamine (10 mM; Calbiochem) were dissolved in 130 mM NaCl and 10 mM HEPES, pH 7.2, and pressure-ejected (Picospritzer II, Parker Instrumentation, Cleveland, OH; five pulses of 3 s duration each, 20 psi). Extracellular application of this vehicle solution has been used in previous studies (Pereda et al., 1992 (Pereda et al., , 1994 Kumar and Faber, 1999) and does not produce changes in recorded synaptic potentials. Ejection from the tip of the microelectrode was routinely verified at the end of each experiment. In the case of intracellular injections, microelectrodes (4-6 MU) contained the PKA inhibitor 5-24 (500 mM; Calbiochem) or the DGL inhibitor THL (100 mM; Sigma) in 0.5 M KCl and 10 mM HEPES, pH 7.2. This vehicle solution does not interfere with the induction of plastic changes (Pereda et al., 1998; Kumar and Faber, 1999) .
Immunohistochemistry
Fish were perfused intracardially with 4% paraformaldehyde. The brain was removed and kept overnight in 4% paraformaldehyde, 30% sucrose phosphate buffer and sectioned with a cryostat (18-50 mm).
The primary antibodies were as follows: monoclonal anti-connexin 35 (1:250; ''anti-Cx35/36,'' MAB3045, Chemicon); polyclonal anticonnexin 35 phosphorylated at serine 110 (1:1000, ''anti-Cx35/ P110,'' John O'Brien) (Kothmann et al., 2007) ; polyclonal antimGluR1a (1:200; ''anti-mGluR1,'' B1551, Chemicon); monoclonal anti-tyrosine hydroxylase (1:500; ''anti-TH,'' MAB318, Chemicon); polyclonal anti-CB 1 carboxy terminus (1:750; ''anti-CB 1 -CT,'' Ken Mackie) (Hajos et al., 2000) ; polyclonal anti-CB 1 residues 1-77 (1:100; ''anti-CB 1 1-77,'' ab3559, Novus) Valenti et al., 2005) , and polyclonal anti-CB 1 residues 1-14 (1:100; ''anti-CB 1 1-14,'' 101500, Cayman) (McIntosh et al., 1998; Yazulla et al., 2000) . Primary antibodies were detected using Alexa Fluor 594 (Molecular Probes A11005) and/or Alexa Fluor 488 (Molecular Probes A11001). Control sections were obtained in the absence of primary antibodies. The sections were examined using a confocal microscope (Olympus Fluoview 500) and analyzed using ImageJ (NIH) and Adobe Photoshop software. The presence of dopamine was revealed with a polyclonal anti-dopamine antibody (Geffard, Bordeaux, France) and an immunoperoxidase reaction using a secondary biotinylated anti-rabbit and avidin-biotin-HRP complex (ABC Vectastain Kit, Vector, USA).
Immunoblotting
For western blots, crude goldfish plasma membranes were prepared by differential centrifugation of fresh tissue homogenates from small portions of goldfish hindbrain containing the M cells . Tissues were homogenized by sonication in ice-cold 0.32 M sucrose, 10 mM Tris-Cl, pH 7.2, 2 mM EGTA, 5 mM MgCl 2 , 1% phosphatase inhibitor cocktail (Sigma), 1% protease inhibitor cocktail for His-tagged proteins (Sigma). The suspension was centrifuged for 5 min at 1000 3 g to remove large particulates, and the supernatant was centrifuged for 1 hr at 100,000 3 g to pellet membranes. The membrane pellet was resuspended in the homogenization medium without protease or phosphatase inhibitors plus 0.5% Igepal CA-630. Protein concentration was measured by the BCA assay (Pierce). For each membrane preparation, a portion was digested with bacterial alkaline phosphatase. The membrane preparations were diluted to 4 mg protein/ml with alkaline phosphatase assay buffer (final composition: 10 mM Tris-Cl, 10 mM MgCl 2 , 0.5% Igepal CA-630, 30% membrane homogenization buffer) and digested with 25 units alkaline phosphatase (Fermentas, Hanover, MD) per mg protein for 2 hr at 50 C. The samples were then diluted to 2 mg protein/ml with 23 SDS sample buffer. Comparable nondigested samples were prepared at the same concentration with alkaline phosphatase buffer but no enzyme. For Cx35 immunoblots, 50 mg aliquots of membrane protein were dissolved in reducing SDS sample buffer and resolved on 12% gels. Proteins were transferred at 18 V overnight to polyvinylidenedifluoride membranes. Blots were blocked with 5% nonfat dry milk in TBST (137 mM NaCl, 3 mM KCl, 25 mM pH 7.4, for 1 hr at room temperature. Blots were incubated with affinitypurified phospho-Ser110-specific antibodies (''anti-Cx35/P110,'' John O'Brien) (Kothmann et al., 2007) diluted to 0.8 mg/ml in highsalt TBST (500 mM NaCl, 3 mM KCl, 25 mM Tris-Cl, pH 7.4, 0.1% Tween-20) plus 2% nonfat dry milk. Blots were also probed with a monoclonal anti-Cx35/36 antibody (MAB3045, Chemicon) at 1 mg/ml under the same conditions. Blots were developed with peroxidase-linked secondary antibodies (Pierce) and detected by chemiluminescence.
